HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

452.836

+4.2090.94%

Number of Gainers:30

Number of Losers:15

Number of Flat:6

PE:- -

High:457.290

Open:448.491

Low:444.171

Close:448.627

Volume:358.40M

Turnover:10.42B

Market Cap:2.91T

Float Cap:1.99T

Loading ...

Innovent Biologics - Jaypirca (Pirtrobrutinib) Approved in China for Cll/Sll Across All Lines of Therapy

THOMSON REUTERS

3SBIO Spends HK$20.41 Million to Buy Back 1.3 Million Shares on September 28

AK Medical Spends HK$242,000 on Buyback of 50,000 Shares on September 28

JD Health International Stock Rises 1.3% in Hong Kong

China Resources Beer (Holdings) Stock Advances 2.6% in Hong Kong

China Resources Mixc Lifestyle Services Stock Climbs 2.9% in Hong Kong

AH Premium Statistics: September 28

JPMorgan: Merck/Daiichi Sankyo Withdrawal of B7-H3 ADC Filing Is a Positive for Hansoh Pharma/GSK's Ris-Rez

Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together

West District Statistics Bureau Releases Sixth Batch of Statistical Enforcement Inspection List for 2026

Citi Turns Bullish on AI-Focused Software Names, Upgrades Kingdee International, Chinasoft International and Thunder Software

Hansoh Pharma to Challenge EU Marketing Revocation for Aumolertinib

MT Newswires Live

ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25

EDDING GENOR Spends HK$6.8 Million to Repurchase 4 Million Shares on September 25

Innovent Expands Phase 3 MarsLight-11 Trial of Ibi363/tak-928 to Include Non-Squamous NSCLC Patients

Innovent Announces Expansion of Global Phase 3 Marslight-11 Study of Ibi363/Tak-928 (Alpha-Biased Il-2/Pd-1 Bispecific Fusion Protein) in Immunotherapy-Resistant Nsclc to Include Patients with Non-Squamous Nsclc

THOMSON REUTERS

HYGEIA HEALTH Spends HKD 2.9998 Million to Buy Back 311,800 Shares on September 25

Xinyi Energy Spends HK$1.5444 Million to Buy Back 1.98 Million Shares on September 25

Xinyi Energy's New Energy Photovoltaic REIT Application Accepted by Shenzhen Stock Exchange

Hansoh Pharma EU Marketing Authorization for Aumseqa Withdrawn, Company Plans to Resubmit Application

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1583/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":452.83566,"timestamp":1791533285939,"preClose":448.62683,"halted":0,"volume":358400549,"delay":0,"changeRate":0.009382,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":4.208832,"latestTime":"10-09 16:00:00","open":448.49072,"high":457.28986,"low":444.17084,"amount":10420978420.5,"amplitude":0.029243,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1791509400000,1791518400000],[1791522000000,1791532800000]],"pbRate":2.054451,"peRate":43.396352,"turnoverRate":0.003292,"increases":28,"decrements":18,"flats":3,"marketCap":2905138834048,"floatMarketCap":1987470167872},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":457.28986,"amplitude":0.029243,"preClose":448.62683,"low":444.17084,"pbRate":"2.054451","latestPrice":452.83566,"volume":358400549,"delay":0,"open":448.49072,"prevYearClose":503.90085,"prevWeekClose":455.58,"prevMonthClose":469.859,"prevQuarterClose":469.859,"fiveDayClose":455.58,"twentyDayClose":453.486,"sixtyDayClose":466.284,"secType":"PLATE","market":"HK","turnoverRate":0.003292,"peRate":43.396352,"marketCap":2905138834048,"floatMarketCap":1987470167872,"timestamp":1791533285939,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":30,"down":15,"flat":6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670236395","title":"Innovent Biologics - Jaypirca (Pirtrobrutinib) Approved in China for Cll/Sll Across All Lines of Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2670236395","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670236395?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:11","pubTimestamp":1790590260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45I0DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","LU1188198961.HKD","LU0607220059.USD","LU2097828557.USD","LU0463099449.HKD","LU0502904849.HKD","LU1831875114.USD","LU0149534421.HKD","LU1969619763.USD","LU2097828714.EUR","HK0000165453.HKD","BK1589","LU0455707207.USD","LU2328871848.SGD","BK1161","LU0326950275.SGD","KURE","LU2097828805.USD","01801","LU2097828474.EUR","LU2242644610.SGD","LU2097828631.EUR","BK1583","LU0244354667.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109899868","title":"3SBIO Spends HK$20.41 Million to Buy Back 1.3 Million Shares on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1109899868","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109899868?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:06","pubTimestamp":1790589979,"startTime":"0","endTime":"0","summary":"3SBIO (01530) announced that the company repurchased 1.3 million shares on September 28, 2026, for a total of HK$20.41 million, at a price range of HK$15.6 to HK$15.8 per share.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01530","BK1593","HK0000165453.HKD","BK1161","HELS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163578787","title":"AK Medical Spends HK$242,000 on Buyback of 50,000 Shares on September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1163578787","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163578787?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:24","pubTimestamp":1790587467,"startTime":"0","endTime":"0","summary":"AK Medical (01789) announced that on September 28, 2026, it spent HK$242,000 to repurchase 50,000 shares.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","BK1585","BK1583","01789","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670228080","title":"JD Health International Stock Rises 1.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2670228080","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670228080?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:33","pubTimestamp":1790584380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. rallied 1.3% to 35.54 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.The stock's rise snapped a four-day losing streak.JD Health International Inc. closed 50% short of its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 8.2 million shares, compared to the 50-day average of 8.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1571","SGXZ86797644.SGD","BK1247","LU0456827905.SGD","86618","BK1589","SGXZ62798434.SGD","06618","BK1583","BK1615","LU0051755006.USD","BK1142","BK1591","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670328080","title":"China Resources Beer (Holdings) Stock Advances 2.6% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2670328080","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670328080?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:32","pubTimestamp":1790584320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of China Resources Beer  Co. Ltd. rallied 2.6% to 18.87 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.China Resources Beer  Co. Ltd. closed 35% below its 52-week high of HK$29.10, which the company reached Nov. 13.Trading volume totaled 8.1 million shares, compared to the 50-day average of 12.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00291","BK1521","IE0008368742.USD","BK1180","BK1583","IE00B543WZ88.USD","BK1578","IE00B0169L03.USD","LU0359202008.SGD","SG9999006514.SGD","IE0031814852.USD","BK1570","LU0359201612.USD","LU1769817096.USD","LU1328615791.USD","BK1510","BK1604","80291","LU1023057109.AUD","IE00BPRC5H50.USD","LU1794554557.SGD","BK1589","LU0328353924.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","IE00B29SXG58.USD","LU1769817179.HKD","LU1720050803.USD","IE0008369823.USD","CRHKY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670280377","title":"China Resources Mixc Lifestyle Services Stock Climbs 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2670280377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670280377?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:31","pubTimestamp":1790584260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of China Resources Mixc Lifestyle Services Ltd. advanced 2.9% to 38.08 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.The stock's rise snapped a two-day losing streak.China Resources Mixc Lifestyle Services Ltd. closed 26% below its 52-week high of HK$51.15, which the company reached May 14.Trading volume totaled 5.6 million shares, compared to the 50-day average of 4.9 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0051755006.USD","BK1542","LU0164939612.USD","LU0456827905.SGD","LU0456846285.SGD","LU0082770016.USD","LU0620787316.HKD","BK1258","BK1583","01209","LU0082770016.SGD","BK1229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141088297","title":"AH Premium Statistics: September 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1141088297","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141088297?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:18","pubTimestamp":1790583512,"startTime":"0","endTime":"0","summary":"As of the close on September 28, NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) occupied the top three positions in AH premium rates, with premiums of 1155.81%, 388.12%, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1655091616.SGD","LU2097828557.USD","LU2476274720.SGD","LU1794554557.SGD","BK1171","82846","HK0000352382.USD","BK1544","IE00B29SXG58.USD","LU0328353924.USD","LU0868486357.SGD","LU0214875030.USD","LU0370786039.SGD","LU0648948544.HKD","IE00BZ08YT58.USD","LU1328277881.USD","EWH","03986","00895","LU1808992512.USD","BK1537","BK1592","BK1583","LU0417516738.SGD","LU0348816934.USD","LU0266512473.USD","03130","BK1163","BK1564","LU0345780521.USD","01108","IE0034224299.USD","LU0229945570.USD","LU0456854461.SGD","LU1366334578.USD","LU0737861772.HKD","LU0106252389.USD","BK1148","LU1880383440.USD","BK1181","LU0516423091.SGD","00991","LU0589944569.HKD","LU1242518857.USD","LU0327786744.USD","LU1105468828.SGD","LU0540923850.HKD","LU0096374516.USD","LU0106959298.USD","LU0531971595.HKD","BK1562","01057","IE00B3M56506.USD","IE00BMCWC346.EUR","BK1530","LU1064131342.USD","IE00B0169L03.USD","LU1282649810.SGD","LU0326950275.SGD","LU2045819591.USD","SG9999011746.SGD","LU1807302812.USD","LU0149534421.HKD","03678","LU2039709279.SGD","LU2394011477.USD","LU0823426480.USD","LU0456827905.SGD","BK1505","LU0348814723.USD","LU0266512127.USD","BK1546","LU0164865239.USD","07233","LU1171460220.USD","83188","LU0449509016.USD","LU1303224171.USD","IE00BYV24P56.USD","LU1961090484.USD","LU2008162690.USD","LU1244550221.USD","LU0165289439.USD","06067","LU0516422952.EUR","LU0244354667.USD","LU0880133367.SGD","LU1008478684.HKD","LU0708995583.HKD","06127","LU2476274308.USD","00187","LU0886674414.USD","IE00BZ08YR35.GBP","LU2097828714.EUR","LU1282649141.HKD","02768","LU1770034418.SGD","BK1223","HK0000352291.HKD","LU0210526637.USD","LU0163747925.USD","03143","LU0211977185.USD","LU0320764599.SGD","BK1507","SG9999014674.SGD","IE00BVYPNQ40.USD","LU2097828474.EUR","LU2125910500.SGD","LU0052750758.USD","LU2279858448.HKD","LU1152091168.USD","LU1023057109.AUD","LU0039217434.USD","LU1244550494.USD","HK0000306685.HKD","83130","LU1226287529.USD","LU0828238088.HKD","LU0737861699.HKD","03188","LU0543330483.HKD","LU1688375341.USD","399300","LU0823426308.USD","02359","IE00B031J352.USD","LU0509642566.USD","LU1785774172.SGD","LU1282648689.USD","LU0828237510.HKD","BK1110","BK1116","LU0287142896.SGD","LU1719994722.HKD","SG9999002828.SGD","IE00BGHQDM52.EUR","LU0640798160.USD","LU0862451753.SGD","LU0140636845.USD","LU3063872942.SGD","LU0561508036.HKD","LU0348805143.USD","LU0117841782.USD","03328","LU0359201612.USD","BK1141","LU0348766576.USD","LU0516422366.SGD","00811","LU0531970944.HKD","LU0797268264.HKD","LU0043850808.USD","82843","BK1105","LU0048580855.USD","HK0000320223.HKD","LU0593848301.USD","LU0871576103.HKD","03968","BK1149","LU0543330566.HKD","LU0828237940.HKD","IE0032431581.USD","LU0072913022.USD","BK1125","01033","LU0329678170.USD","IE00B543WZ88.USD","LU2264538146.SGD","HK0000320264.USD","BK1610","LU0463099449.HKD","LU1115378108.SGD","LU0384037296.USD","LU2226246903.HKD","LU0469268626.HKD","LU0164939612.USD","SG9999001093.SGD","SG9999004220.SGD","LU0228659784.USD","LU2399975544.HKD","LU0164880469.USD","00638","02068","LU0488056044.USD","02701","02822","LU2294711473.HKD","00317","IE0031814852.USD","02475","LU0254981946.USD","LU0029875118.USD","LU0128522157.USD","LU1242518931.SGD","BK1130","LU0417516902.SGD","LU1152091754.HKD","LU0791590937.USD","LU0228367735.SGD","LU1224709979.USD","IE00BZ08YS42.EUR","06951","LU0348825331.USD","LU0918141887.USD","LU1244550577.SGD","LU0501845795.SGD","BK1522","LU0455707207.USD","02218","IE0008369823.USD","LU1880383366.USD","LU0149721374.USD","LU0634319403.HKD","LU1211504680.USD","LU2097828631.EUR","BK1198","LU0791591158.USD","02823","06821","SG9999006597.SGD","LU1188198961.HKD","LU0315179316.USD","LU1481107354.HKD","LU0979878070.USD","02843","02338","LU1960683339.HKD","BK1183","IE0008368742.USD","LU0329678337.USD","00300","LU1720050803.USD","LU0345780281.USD","LU0231483743.USD","BK1552","LU0620787316.HKD","LU1504937902.USD","82822","BK1594","LU0348735423.USD","LU0049853897.USD","LU0067412154.USD","BK1144","LU0607220059.USD","00699","HK0000306701.USD","LU0181495838.USD","LU1769817096.USD","BK1202","BK1554","BK1514","LU0431992006.USD","BK1240","IE00BF5LJ272.USD","LU2177674079.SGD","BK1140","BK1191","BK1560","LU1206782309.USD","BK1509","HK0001040143.USD","03268","82823","BK1190","LU1769817179.HKD","LU0456846285.SGD","LU0359202008.SGD","LU0348827113.USD","BK1576","LU1048596156.SGD","LU0918141705.HKD","02865","LU1831875114.USD","01812","LU1255011170.USD","LU2242644610.SGD","00042","00553","BK1214","BK1170","SG9999002463.SGD","LU0588546209.SGD","BK1147","LU0348788117.USD","02827","LU0516423174.USD","LU1251922891.USD","IE00BVYPNP33.GBP","HK0001040168.HKD","BK1551","LU0320764755.SGD","LU1366334651.USD","LU0502904849.HKD","LU0821914370.USD","LU2778985437.USD","LU0061477393.USD","SG9999001226.SGD","IE00B5MMRT66.SGD","LU0516422440.USD","LU0173614495.USD","02846","LU0051755006.USD","159982","LU2097828805.USD","LU1282649067.USD","LU0972618739.USD","LU0672654166.SGD","LU0082770016.SGD","LU1675838814.USD","03606","01349","LU0307460666.USD","LU0359201885.HKD","LU0269904917.USD","LU0082770016.USD","IE00B031HY20.USD","LU1813983027.USD","LU1993786604.SGD","LU0314109678.HKD","BK1237","LU0348767384.USD","LU1988902786.USD","02899","LU1046422090.SGD","BK1521","LU0890818403.SGD","LU0572944931.SGD","BK1231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170510602","title":"JPMorgan: Merck/Daiichi Sankyo Withdrawal of B7-H3 ADC Filing Is a Positive for Hansoh Pharma/GSK's Ris-Rez","url":"https://stock-news.laohu8.com/highlight/detail?id=1170510602","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170510602?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:09","pubTimestamp":1790582978,"startTime":"0","endTime":"0","summary":"JPMorgan has issued a research report maintaining its \"Overweight\" rating on Hansoh Pharma (03692) with a target price of HK$50.Merck (MRK.US) and Daiichi Sankyo (4568.JP) have voluntarily withdrawn...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000SO60NU8.SGD","IE000WAW04H5.SGD","SG9999002232.USD","LU0149725797.USD","LU0683600562.USD","LU2505996681.GBP","BK4566","LU0689472784.USD","LU1119994496.HKD","IE00BLSP4452.SGD","IE0000B7K699.USD","LU2168564149.EUR","LU2211815571.USD","BK1589","LU1496350171.SGD","LU0170899867.USD","BK1191","BK4550","LU2746668461.USD","LU0640476718.USD","LU2357627491.SGD","LU2023250504.SGD","LU1366192091.USD","LU2023250843.SGD","LU2381873111.SGD","LU1064131342.USD","IE00BKVL7J92.USD","LU0211328371.USD","LU0323591593.USD","BK4585","LU1244550221.USD","LU2237443895.HKD","LU2592432038.USD","LU0345770993.USD","FNCL","LU1914381329.SGD","IXG","IE000MB6IJN5.SGD","LU0496365809.HKD","03692","LU2237443978.SGD","IE00BJLML261.HKD","LU0345770308.USD","BK4207","IE00B1XK9C88.USD","LU0971096721.USD","IE000M9KFDE8.USD","UYG","FTXO","BK4533","LU0211326839.USD","LU1551013425.SGD","KBWB","LU0265550946.USD","XLF","LU0187121727.USD","LU0211326755.USD","LU2552382132.HKD","IE00BWXC8680.SGD","IE00BDCRKT87.USD","LU0345769631.USD","SG9999002224.SGD","IE00BN8TJ469.HKD","LU0310799852.SGD","LU1720051108.HKD","JPO","VFH","LU1261432733.SGD","LU0964807845.USD","LU0256863902.USD","LU0203345920.USD","LU2168564065.EUR","LU0106261372.USD","LU2462157665.USD","LU2168564495.EUR","LU2168563687.JPY","LU2237443549.SGD","BK4504","LU2552382058.USD","LU1629891620.HKD","LU0211331839.USD","IE00BZ1G4Q59.USD","IE00BK4W5M84.HKD","IE00BJTD4V19.USD","LU2552382215.SGD","LU0320765646.SGD","LU1244550494.USD","LU0265550359.USD","LU0345769128.USD","TRUF","LU0211327993.USD","LU0868494617.USD","LU0157215616.USD","LU0208291251.USD","LU1116320737.USD","LU0106831901.USD","LU1116320901.HKD","IE00BDRTCR15.USD","LU2746668974.SGD","BK4581","LU0256863811.USD","LU1084165304.USD","LU2242649171.HKD","LU0882574139.USD","IE00BLSP4239.USD","LU2264538146.SGD","LU0868494708.USD","LU2456880835.USD","IE00BBT3K403.USD","LU0820561909.HKD","IE0034235188.USD","BK4534","LU1988902786.USD","LU2236285917.USD","LU2237443465.HKD","LU1496350502.SGD","LU2430703095.HKD","IE00BHPRN162.USD","LU0234572021.USD","LU1280957306.USD","LU1894683264.USD","LU2237443382.USD","LU2756315318.SGD","IE00BYXW3230.USD","LU0251132253.USD","IE0034235303.USD","LU0203347892.USD","LU0267386448.USD","LU1670627923.USD","LU2430703178.SGD","LU1548497426.USD","LU0006306889.USD","LU2756315664.SGD","LU2244417387.USD","LU0238689110.USD","LU1267930490.SGD","LU1244550577.SGD","IE00BJTD4N35.SGD","LU2023250330.USD","BK4588","LU2237443622.USD","JPM","LU0787776722.HKD","IE0034235295.USD","LU2417539215.USD","LU0048584097.USD","IE00B775SV38.USD","LU1162221912.USD","IE00B1BXHZ80.USD","LU2054465674.USD","LU0976567544.SGD","LU1145028129.USD","LU0215105999.USD","LU1366333091.USD","LU1917777945.USD","IE000F7OJYX1.SGD","IYG","LU0070302665.USD","LU1720051017.SGD","LU1670628061.USD","BK1583","BK4516","IE00B3S45H60.SGD","LU0942090050.USD","LU0417517546.SGD","LU0820562030.AUD","LU2357305700.SGD","LU1894683348.USD","IE00BK4W5L77.USD","IE00BKDWB100.SGD","LU2106854487.HKD","IYF","LU0234570918.USD","LU1363072403.SGD","LU1974910355.USD","LU2430703251.USD","TFNS","LU1032466523.USD","LU1668664300.SGD","IE000BZT7R73.USD","IE00BFXG1179.USD","LU0820561818.USD","LU2168564222.USD","LU1551013342.USD","LU0859254822.USD","LU0943347566.SGD","LU0320765489.SGD","JPMO","LU2213496289.HKD","LU2505996509.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132272624","title":"Healthcare Shows Resilience! Pharma ETF Huabao (562050) Rises Against the Market, Livzon Pharmaceutical Group Hits Limit Up! Medical Devices Show Localized Strength, Mindray and United Imaging Advance Together","url":"https://stock-news.laohu8.com/highlight/detail?id=1132272624","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132272624?lang=en_us&edition=fundamental","pubTime":"2026-09-28 13:22","pubTimestamp":1790572929,"startTime":"0","endTime":"0","summary":"On the first trading day after the Mid-Autumn Festival (September 28), A-shares underwent a deep correction, with the Shanghai Composite Index falling nearly 2% at one point. Pharmaceutical assets...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK0028","BK1574","159883","BK1100","BK1515","BK1583","IEIH","LGHT","BK0187","HART","RSPH","562050","GDOC","MEDX","BK1161","LNGR","BK0239","MDEV","PTH","AGNG","159938","BK0188","000513","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154751421","title":"West District Statistics Bureau Releases Sixth Batch of Statistical Enforcement Inspection List for 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1154751421","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154751421?lang=en_us&edition=fundamental","pubTime":"2026-09-28 11:20","pubTimestamp":1790565659,"startTime":"0","endTime":"0","summary":"The West District Statistics Bureau has published its sixth batch of statistical enforcement inspection targets for 2026, covering a broad range of enterprises and institutions operating across the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1229","06958","01971","BK1542","BK1258","09983"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103656038","title":"Citi Turns Bullish on AI-Focused Software Names, Upgrades Kingdee International, Chinasoft International and Thunder Software","url":"https://stock-news.laohu8.com/highlight/detail?id=1103656038","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103656038?lang=en_us&edition=fundamental","pubTime":"2026-09-28 11:09","pubTimestamp":1790564942,"startTime":"0","endTime":"0","summary":"Citi released a research report stating that despite continued weakness in IT spending, after three consecutive years of earnings estimate downgrades for China's intelligent transportation systems...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","LU0162691827.USD","AIPO","BK0231","BK4534","LU0310800965.SGD","BK4566","BK4585","BK0065","LU0314106906.USD","LU1074936037.SGD","LU0140636845.USD","LU1244550221.USD","LU0130517989.USD","LU1201861249.SGD","BK0201","LU0320765646.SGD","BK1586","BK0090","BK1526","00268","LU0203345920.USD","LU1791807156.HKD","LU1267930227.SGD","LU2360032135.SGD","00354","LU0072461881.USD","BK0108","BK1618","BK1589","LU1244550494.USD","LU2125154778.USD","300496","BK1117","BK1155","00909","LU1506573853.SGD","LU0128525689.USD","LU2417539215.USD","BK1109","LU2456880835.USD","ARTY","LU1144417596.USD","LU2236285917.USD","BK4588","LU0130102774.USD","VTHR","LU1048588211.SGD","LU1162221912.USD","IE0034224299.USD","BK4207","LU0203347892.USD","CHAT","AGIX","LU2125154935.USD","BK4559","QTOC","IE00BSNM7G36.USD","C","TFNS","BK1517","BK0128","LU0051755006.USD","FTXO","LU2462157665.USD","LU0648001328.SGD","BK4504","LU0477156953.USD","BK1607","BK1583","LU1244550577.SGD","LU0456827905.SGD","LU0980610538.SGD","LU1366192091.USD","BK1518","LU0072462343.USD","BK1613","LU0106831901.USD","LU0052756011.USD","LU0098860793.USD","IYF","LU0170899867.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670407632","title":"Hansoh Pharma to Challenge EU Marketing Revocation for Aumolertinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2670407632","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670407632?lang=en_us&edition=fundamental","pubTime":"2026-09-28 09:17","pubTimestamp":1790558271,"startTime":"0","endTime":"0","summary":"Hansoh Pharmaceutical  said it will challenge the European Commission's decision to revoke the marketing authorization for Aumolertinib, marketed as Aumseqa outside China, in the European Union, according to a Sunday Hong Kong bourse filing.The decision relates to a procedural issue involving clinical results for AstraZeneca's Tagrisso that were referenced in its 2022 marketing application.The relevant data protection period expired in 2024, Hansoh said.Hansoh said the decision does not relate to the product's quality, safety, efficacy or clinical value.The company plans to challenge the decision if necessary and resubmit its marketing application to the European Medicines Agency based on the original data package.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","BK1191","03692","BK1589","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196699729","title":"ZYLOXTB Spends HK$1.1571 Million to Buy Back 54,000 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1196699729","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196699729?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:50","pubTimestamp":1790556615,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) has released an announcement stating that on September 25, 2026, the company spent HK$1.1571 million to repurchase 54,000 shares.The announcement disclosed the share buyback details, with the company allocating HK$1.1571 million for the repurchase of 54,000 shares on that date.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1583","BK1574","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121417907","title":"EDDING GENOR Spends HK$6.8 Million to Repurchase 4 Million Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1121417907","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121417907?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:40","pubTimestamp":1790556031,"startTime":"0","endTime":"0","summary":"EDDING GENOR (06998) has issued an announcement stating that on September 25, 2026, the company spent HK$6.8 million to repurchase 4 million shares, with a repurchase price of HK$1.695 to HK$1.7 per share.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","06998","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402351","title":"Innovent Expands Phase 3 MarsLight-11 Trial of Ibi363/tak-928 to Include Non-Squamous NSCLC Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402351","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402351?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:00","pubTimestamp":1790553625,"startTime":"0","endTime":"0","summary":"Innovent expands Phase 3 MarsLight-11 trial of IBI363/TAK-928 to include non-squamous NSCLC patientsInnovent Biologics expanded its global Phase 3 MarsLight-11 trial of IBI363/TAK-928 to include non-s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8bvkF3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU0149534421.HKD","LU2097828474.EUR","LU1831875114.USD","LU2328871848.SGD","LU2097828631.EUR","LU0502904849.HKD","LU1969619763.USD","LU0455707207.USD","LU2097828805.USD","LU0463099449.HKD","BK1161","LU2097828557.USD","LU2488822045.USD","LU0607220059.USD","01801","BK1589","LU0244354667.USD","LU2242644610.SGD","HK0000165453.HKD","LU1188198961.HKD","LU2097828714.EUR","01911","KURE","BK1147","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670402334","title":"Innovent Announces Expansion of Global Phase 3 Marslight-11 Study of Ibi363/Tak-928 (Alpha-Biased Il-2/Pd-1 Bispecific Fusion Protein) in Immunotherapy-Resistant Nsclc to Include Patients with Non-Squamous Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2670402334","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670402334?lang=en_us&edition=fundamental","pubTime":"2026-09-28 08:00","pubTimestamp":1790553600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nTUAQM6DS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01801","LU2097828805.USD","LU0149534421.HKD","LU0502904849.HKD","BK1589","LU0455707207.USD","BK1161","LU0244354667.USD","LU2097828631.EUR","LU0607220059.USD","LU0463099449.HKD","LU0326950275.SGD","LU2097828474.EUR","LU1188198961.HKD","BK1583","LU2242644610.SGD","LU2488822045.USD","LU2097828714.EUR","LU1831875114.USD","LU2328871848.SGD","LU1969619763.USD","HK0000165453.HKD","KURE","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136724782","title":"HYGEIA HEALTH Spends HKD 2.9998 Million to Buy Back 311,800 Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1136724782","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136724782?lang=en_us&edition=fundamental","pubTime":"2026-09-28 07:40","pubTimestamp":1790552426,"startTime":"0","endTime":"0","summary":"HYGEIA HEALTH (06078) has announced that on September 25, 2026, the company spent HKD 2.9998 million to repurchase 311,800 shares.The buyback was disclosed through a formal company announcement, confirming the total consideration paid for the repurchased shares.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1209","LU0329678170.USD","LU0737861772.HKD","LU2488822045.USD","LU0329678337.USD","06078","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134416323","title":"Xinyi Energy Spends HK$1.5444 Million to Buy Back 1.98 Million Shares on September 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1134416323","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134416323?lang=en_us&edition=fundamental","pubTime":"2026-09-28 07:40","pubTimestamp":1790552422,"startTime":"0","endTime":"0","summary":"On September 25, 2026, XINYI ENERGY (03868) announced that it spent HK$1.5444 million to repurchase 1.98 million shares.The company disclosed the buyback in a filing, detailing the total amount paid for the share repurchase on that date.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1594","03868","BK1583","BK1154","BK1554"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100034599","title":"Xinyi Energy's New Energy Photovoltaic REIT Application Accepted by Shenzhen Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=1100034599","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100034599?lang=en_us&edition=fundamental","pubTime":"2026-09-27 18:56","pubTimestamp":1790506574,"startTime":"0","endTime":"0","summary":"Xinyi Energy (03868) and Xinyi Solar (00968) jointly announced that, following a recommendation received from the China Securities Regulatory Commission on August 26, 2026, the fund manager submitted...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDIV","DFRA","BK1554","RJMG","399941","RNTY","RAYS","159875","IQRA","PSCF","YLDW","000941.SH","BK1154","BK1583","160640","BK1594","03868","BPRE","IVRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101814081","title":"Hansoh Pharma EU Marketing Authorization for Aumseqa Withdrawn, Company Plans to Resubmit Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1101814081","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101814081?lang=en_us&edition=fundamental","pubTime":"2026-09-27 18:26","pubTimestamp":1790504774,"startTime":"0","endTime":"0","summary":"Hansoh Pharma (03692) announced that the EU marketing authorization for ametinib (overseas brand name: Aumseqa®) as a monotherapy was withdrawn following a decision by the European Commission's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","FESXmain","FSXEmain","BK1191","IPOS","03692","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":10,"totalSize":203,"code":"91000000","status":"200"}]}}